MAPK3 and melanoma: Apigenin substantially inhibits cell proliferation, invasion, migration, and triggered G2/M phase arrest and death in human melanoma A375 and C8161 cell lines, and reduces the activity of p-ERK1/2, p-AKT, and p-mTOR [140].